Ultrasound Triggered Release of Estrone- Targeted Liposomes

A Master of Science thesis in Chemical Engineering by Pierre Kawak entitled, "Ultrasound Triggered Release of Estrone- Targeted Liposomes," submitted in May 2017. Thesis advisor is Dr. Ghaleb Husseini. Soft and hard copy available.

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Kawak, Pierre (author)
التنسيق: doctoralThesis
منشور في: 2017
الموضوعات:
الوصول للمادة أونلاين:http://hdl.handle.net/11073/8858
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513443664494592
author Kawak, Pierre
author_facet Kawak, Pierre
author_role author
dc.contributor.none.fl_str_mv Husseini, Ghaleb
dc.creator.none.fl_str_mv Kawak, Pierre
dc.date.none.fl_str_mv 2017-06-01T07:18:39Z
2017-06-01T07:18:39Z
2017-05
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv 35.232-2017.11
http://hdl.handle.net/11073/8858
dc.language.none.fl_str_mv en_US
dc.subject.none.fl_str_mv Drug Delivery
Liposomes
Breast Cancer
Doxorubicin
Ultrasound
Estrone
Active Targeting
Liposomes
Drug-delivery systems
Therapeutic use
Ultrasonics in medicine
Cancer
Treatement
Technological innovations
Estrone
dc.title.none.fl_str_mv Ultrasound Triggered Release of Estrone- Targeted Liposomes
Ultrasound Triggered Release of Estrone-Targeted Liposomes
dc.type.none.fl_str_mv info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/doctoralThesis
description A Master of Science thesis in Chemical Engineering by Pierre Kawak entitled, "Ultrasound Triggered Release of Estrone- Targeted Liposomes," submitted in May 2017. Thesis advisor is Dr. Ghaleb Husseini. Soft and hard copy available.
format doctoralThesis
id aus_e16f785aff575f0348375f9487bb4ae5
identifier_str_mv 35.232-2017.11
language_invalid_str_mv en_US
network_acronym_str aus
network_name_str aus
oai_identifier_str oai:repository.aus.edu:11073/8858
publishDate 2017
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Ultrasound Triggered Release of Estrone- Targeted LiposomesUltrasound Triggered Release of Estrone-Targeted LiposomesKawak, PierreDrug DeliveryLiposomesBreast CancerDoxorubicinUltrasoundEstroneActive TargetingLiposomesDrug-delivery systemsTherapeutic useUltrasonics in medicineCancerTreatementTechnological innovationsEstroneA Master of Science thesis in Chemical Engineering by Pierre Kawak entitled, "Ultrasound Triggered Release of Estrone- Targeted Liposomes," submitted in May 2017. Thesis advisor is Dr. Ghaleb Husseini. Soft and hard copy available.The fight against cancer has proven to be a lengthy one. Conventional treatment of cancer usually involves chemotherapy, a therapy known for its detrimental side effects. Doxorubicin, a cytotoxic anthracycline antibiotic, is one example of a chemotherapeutic drug that can cause congestive heart failure and other heart-related problems. Drug Delivery Systems (DDS) solve this problem by guarding healthy cells against the effects of chemotherapeutic drugs, while focusing their effect on the diseased tissue. Breast cancer is known to overexpress estrone receptors. This study deals with one DDS: estrone-targeted liposomes incapsulating doxorubicin and its efficacy when used in conjunction with ultrasound for the treatment of breast cancer. The DDS should protect healthy cells from the drug, transport the drug selectively to the cancer cells and release its contents in response to focused ultrasound (US). Two types of carriers were developed and studied: ES-positive and ES-negative liposomes. These DDS were found to be Large Unilamellar Vesicles, or LUVs, with radii of 97.11 ± 6.46 nm and 77.29 ± 0.43 nm, respectively, with uniform distributions. Release triggered by low frequency US was studied using a 20-kHz frequency probe at three power densities: 0.7, 3.09 and 5.25 mW/cm2. An increase in power density caused an increase in the release rate recorded. Comparing both targeted and non-targeted liposomes, the ES-positive ones were found to be more stable and less sonosensitive. High frequency US was studied as a trigger mechanism and no effect was discerned after an hour and a half of application. Comparisons with previous work showed a lower release rate compared to calcein-incorporating liposomes, as well as to doxorubicin-encapsulating micelles and the implications were discussed. Several drug release models were used to model experimental data and the Higuchi Kinetics model was found to be the best fit indicating diffusion-driven release by US. No statistically significant difference was found between the release rate constants of both liposomes under investigation and the different power densities investigated. The average release rate constant was 0.054 %/s.College of EngineeringDepartment of Chemical EngineeringMaster of Science in Chemical Engineering (MSChE)Husseini, Ghaleb2017-06-01T07:18:39Z2017-06-01T07:18:39Z2017-05info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisapplication/pdf35.232-2017.11http://hdl.handle.net/11073/8858en_USoai:repository.aus.edu:11073/88582025-06-26T12:32:43Z
spellingShingle Ultrasound Triggered Release of Estrone- Targeted Liposomes
Kawak, Pierre
Drug Delivery
Liposomes
Breast Cancer
Doxorubicin
Ultrasound
Estrone
Active Targeting
Liposomes
Drug-delivery systems
Therapeutic use
Ultrasonics in medicine
Cancer
Treatement
Technological innovations
Estrone
status_str publishedVersion
title Ultrasound Triggered Release of Estrone- Targeted Liposomes
title_full Ultrasound Triggered Release of Estrone- Targeted Liposomes
title_fullStr Ultrasound Triggered Release of Estrone- Targeted Liposomes
title_full_unstemmed Ultrasound Triggered Release of Estrone- Targeted Liposomes
title_short Ultrasound Triggered Release of Estrone- Targeted Liposomes
title_sort Ultrasound Triggered Release of Estrone- Targeted Liposomes
topic Drug Delivery
Liposomes
Breast Cancer
Doxorubicin
Ultrasound
Estrone
Active Targeting
Liposomes
Drug-delivery systems
Therapeutic use
Ultrasonics in medicine
Cancer
Treatement
Technological innovations
Estrone
url http://hdl.handle.net/11073/8858